These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1973822)

  • 1. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus.
    Gutierrez-Ramos JC; Andreu JL; Revilla Y; Viñuela E; Martinez C
    Nature; 1990 Jul; 346(6281):271-4. PubMed ID: 1973822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.
    Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC
    J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signals required for activation and growth of autoimmune T lymphocytes.
    Santoro TJ; Malek TR; Rosenberg YJ; Morse HC; Steinberg AD
    J Mol Cell Immunol; 1984; 1(6):347-56. PubMed ID: 6086044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of intermediate T-cell receptor cells expanding in the liver, thymus and other organs in autoimmune lpr mice: parallel analysis with their normal counterparts.
    Iiai T; Kimura M; Kawachi Y; Hirokawa K; Watanabe H; Hatakeyama K; Abo T
    Immunology; 1995 Apr; 84(4):601-8. PubMed ID: 7790034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes.
    Sobel ES; Yokoyama WM; Shevach EM; Eisenberg RA; Cohen PL
    J Immunol; 1993 Jan; 150(2):673-82. PubMed ID: 8380429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice.
    Zhou G; Fujio K; Sadakata A; Okamoto A; Yu R; Yamamoto K
    Clin Exp Immunol; 2004 Jun; 136(3):448-55. PubMed ID: 15147346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
    Apelgren LD; Bailey DL; Fouts RL; Short L; Bryan N; Evans GF; Sandusky GE; Zuckerman SH; Glasebrook A; Bumol TF
    Cell Immunol; 1996 Oct; 173(1):55-63. PubMed ID: 8871601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intact antigen receptor-mediated generation of inositol phosphates and increased intracellular calcium in CD4 CD8 T lymphocytes from MRL lpr mice.
    Budd RC; Winslow G; Inokuchi S; Imboden JB
    J Immunol; 1990 Nov; 145(9):2862-72. PubMed ID: 1976707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
    Chan O; Shlomchik MJ
    J Immunol; 1998 Jan; 160(1):51-9. PubMed ID: 9551955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
    Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
    Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subset of CD4+ T cells expressing early activation antigen CD69 in murine lupus: possible abnormal regulatory role for cytokine imbalance.
    Ishikawa S; Akakura S; Abe M; Terashima K; Chijiiwa K; Nishimura H; Hirose S; Shirai T
    J Immunol; 1998 Aug; 161(3):1267-73. PubMed ID: 9686587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the J11d marker on peripheral T lymphocytes of MRL-lpr/lpr mice.
    Seth A; Pyle RH; Nagarkatti M; Nagarkatti PS
    J Immunol; 1988 Aug; 141(4):1120-5. PubMed ID: 2899601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-B collaboration in the in vitro anti-Sm autoantibody response of MRL/Mp-lpr/lpr mice.
    Shores EW; Eisenberg RA; Cohen PL
    J Immunol; 1988 May; 140(9):2977-82. PubMed ID: 2966204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 induction, response and therapy on murine lupus lesions in the MRL/l strain.
    Abe C; Koyama A; Nishimura T
    Prog Clin Biol Res; 1987; 229():147-56. PubMed ID: 3496609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.